Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jin Zhao, Yan Huang, Jian Li, Bo Zhang, Zhiwei Dong & Dong Wang. (2022) In vitro Antibacterial Activity and Resistance Prevention of Antimicrobial Combinations for Dihydropteroate Synthase-Carrying Stenotrophomonas maltophilia. Infection and Drug Resistance 15, pages 3039-3046.
Read now
Read now
Magnus G. Ahlström, Jenny Dahl Knudsen & Frederik Boëtius Hertz. (2022) Stenotrophomonas maltophilia bacteraemia: 61 cases in a tertiary hospital in Denmark. Infectious Diseases 54:1, pages 26-35.
Read now
Read now
Wentao Ni, Guobao Li, Jin Zhao, Junchang Cui, Rui Wang, Zhancheng Gao & Youning Liu. (2018) Use of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae. Infectious Diseases 50:7, pages 507-513.
Read now
Read now
Articles from other publishers (21)
Maria F. Mojica, Robert A. Bonomo & David van Duin. (2023) Treatment approaches for severe Stenotrophomonas maltophilia infections. Current Opinion in Infectious Diseases 36:6, pages 572-584.
Crossref
Crossref
Masoud Dadashi, Bahareh Hajikhani, Nooshin Nazarinejad, Negin Noorisepehr, Shahrooz Yazdani, Ali Hashemi, Zahra Hashemizadeh, Mehdi Goudarzi & Sameni Fatemeh. (2023) Global prevalence and distribution of antibiotic resistance among clinical isolates of Stenotrophomonas maltophilia: A systematic review and meta-analysis. Journal of Global Antimicrobial Resistance 34, pages 253-267.
Crossref
Crossref
Ashlan J. Kunz Coyne, Shelbye Herbin, Kaylee Caniff & Michael J. Rybak. (2023)
Steno‐sphere: Navigating the enigmatic world of emerging
multidrug‐resistant
Stenotrophomonas maltophilia
. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 43:8, pages 833-846.
Crossref
Crossref
Pranita D Tamma, Samuel L Aitken, Robert A Bonomo, Amy J Mathers, David van Duin & Cornelius J Clancy. (2023) Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Clinical Infectious Diseases.
Crossref
Crossref
Cornelius J. Clancy & Minh Hong Nguyen. (2022) Management of Highly Resistant Gram-Negative Infections in the Intensive Care Unit in the Era of Novel Antibiotics. Infectious Disease Clinics of North America 36:4, pages 791-823.
Crossref
Crossref
Pranita D Tamma, Samuel L Aitken, Robert A Bonomo, Amy J Mathers, David van Duin & Cornelius J Clancy. (2022)
Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-Resistant
Acinetobacter baumannii
, and
Stenotrophomonas maltophilia
Infections
. Clinical Infectious Diseases 74:12, pages 2089-2114.
Crossref
Crossref
Ravina Kullar, Eric Wenzler, Jose Alexander & Ellie J C Goldstein. (2022)
Overcoming
Stenotrophomonas maltophilia
Resistance for a More Rational Therapeutic Approach
. Open Forum Infectious Diseases 9:5.
Crossref
Crossref
Jean Gibb & Darren W. Wong. (2021) Antimicrobial Treatment Strategies for Stenotrophomonas maltophilia: A Focus on Novel Therapies. Antibiotics 10:10, pages 1226.
Crossref
Crossref
Shauna Jacobson Junco, Mary Catherine Bowman & R. Brigg Turner. (2021) Clinical outcomes of Stenotrophomonas maltophilia infection treated with trimethoprim/sulfamethoxazole, minocycline, or fluoroquinolone monotherapy. International Journal of Antimicrobial Agents 58:2, pages 106367.
Crossref
Crossref
Yu-Lan Chen, Hai-Tao Yang, Li-Xiong Liu, Cui-Hong Chen, Qin Huang, Xiao-Ping Hong, Jiu-Liang Zhao & Dong-Zhou Liu. (2020) Dorsolateral medullary infarction during skin infection by Stenotrophomonas maltophilia in a patient with triple antiphospholipid antibody positivity: a case-based review. Clinical Rheumatology 40:7, pages 2965-2971.
Crossref
Crossref
Brianna Kispal & Sandra A. N. Walker. (2020) Monte Carlo simulation evaluation of tigecycline dosing for bacteria with raised minimum inhibitory concentrations in non-critically ill adults. European Journal of Clinical Pharmacology 77:2, pages 197-205.
Crossref
Crossref
Julie E. Farrar, Katelyn M. Garner, Joseph M. Swanson, Louis J. Magnotti, Martin A. Croce & G. Christopher Wood. (2020)
Tigecycline to treat
Stenotrophomonas maltophilia
ventilator‐associated pneumonia in a trauma intensive care unit as a result of a drug shortage: A case series
. Journal of Clinical Pharmacy and Therapeutics 45:4, pages 836-839.
Crossref
Crossref
Bruna Kochhann Menezes, Izabel Almeida Alves, Keli Jaqueline Staudt, Betina Montanari Beltrame, Letícia Venz, Lessandra Michelin, Bibiana Verlindo Araujo & Leandro Tasso. (2019) Time-kill curves of daptomycin and Monte Carlo simulation for the treatment of bacteraemia caused by Enterococcus faecium. Brazilian Journal of Microbiology 51:1, pages 169-176.
Crossref
Crossref
M. Biagi, X. Tan, T. Wu, M. Jurkovic, A. Vialichka, K. Meyer, R. E. Mendes & E. Wenzler. (2020) Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole. Journal of Clinical Microbiology 58:2.
Crossref
Crossref
Cara Nys, Kartik Cherabuddi, Veena Venugopalan & Kenneth P. Klinker. (2019) Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia Infections. Antimicrobial Agents and Chemotherapy 63:11.
Crossref
Crossref
J.-H. Ko, C.-I. Kang, P. Cornejo-Juárez, K.-M. Yeh, C.-H. Wang, S.Y. Cho, M.G. Gözel, S.-H. Kim, P.-R. Hsueh, N. Sekiya, Y. Matsumura, D.-G. Lee, S.-Y. Cho, S. Shiratori, Y.-J. Kim, D.R. Chung & K.R. Peck. (2019) Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis. Clinical Microbiology and Infection 25:5, pages 546-554.
Crossref
Crossref
Jin Zhao, Yunxi Liu, Yi Liu, Dong Wang, Wentao Ni, Rui Wang, Youning Liu & Bo Zhang. (2018) Frequency and Genetic Determinants of Tigecycline Resistance in Clinically Isolated Stenotrophomonas maltophilia in Beijing, China. Frontiers in Microbiology 9.
Crossref
Crossref
Jin Zhao, Yubin Xing, Wei Liu, Wentao Ni, Chuanqi Wei, Rui Wang, Yunxi Liu & Youning Liu. (2016) Surveillance of Dihydropteroate Synthase Genes in Stenotrophomonas maltophilia by LAMP: Implications for Infection Control and Initial Therapy. Frontiers in Microbiology 7.
Crossref
Crossref
. (2016) In the Literature. Clinical Infectious Diseases 63:4, pages iii-iv.
Crossref
Crossref
Piyali Mukherjee & Pranab Roy. (2016) Genomic Potential of Stenotrophomonas maltophilia in Bioremediation with an Assessment of Its Multifaceted Role in Our Environment. Frontiers in Microbiology 7.
Crossref
Crossref
Chuanqi Wei, Wentao Ni, Xuejiu Cai, Jin Zhao & Junchang Cui. (2016) Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments. PLOS ONE 11:3, pages e0152132.
Crossref
Crossref